BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28594328)

  • 1. Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?
    Besheer T; Razek AAKA; El Bendary M; Abd El Maksoud M; Elalfy H; Zalata K; Elkashef W; Zaghloul H; El Gilany AH
    Turk J Gastroenterol; 2017 Jul; 28(4):283-288. PubMed ID: 28594328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus.
    Besheer T; Elalfy H; Abd El-Maksoud M; Abd El-Razek A; Taman S; Zalata K; Elkashef W; Zaghloul H; Elshahawy H; Raafat D; Elemshaty W; Elsayed E; El-Gilany AH; El-Bendary M
    World J Gastroenterol; 2019 Mar; 25(11):1366-1377. PubMed ID: 30918429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Liver Fibrosis with Diffusion-Weighted Magnetic Resonance Imaging Using Different b-values in Chronic Viral Hepatitis.
    Kocakoc E; Bakan AA; Poyrazoglu OK; Dagli AF; Gul Y; Cicekci M; Bahcecioglu IH
    Med Princ Pract; 2015; 24(6):522-6. PubMed ID: 26183515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].
    Zhou ML; Yan FH; Xu PJ; Chen CZ; Shen JZ; Li RC; Ji Y; Shi JY
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1757-61. PubMed ID: 19862980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
    Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion kurtosis imaging with the breath-hold technique for staging hepatic fibrosis: A preliminary study.
    Yoshimaru D; Miyati T; Suzuki Y; Hamada Y; Mogi N; Funaki A; Tabata A; Masunaga A; Shimada M; Tobari M; Nishino T
    Magn Reson Imaging; 2018 Apr; 47():33-38. PubMed ID: 29158186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease.
    Tokgöz Ö; Unal I; Turgut GG; Yildiz S
    Acta Clin Belg; 2014 Dec; 69(6):426-32. PubMed ID: 25103596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance imaging for the assessment of liver fibrosis in chronic viral hepatitis.
    Charatcharoenwitthaya P; Sukonrut K; Korpraphong P; Pongpaibul A; Saiviroonporn P
    PLoS One; 2021; 16(3):e0248024. PubMed ID: 33662022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B.
    Hennedige TP; Wang G; Leung FP; Alsaif HS; Teo LL; Lim SG; Wee A; Venkatesh SK
    Gut Liver; 2017 May; 11(3):401-408. PubMed ID: 27965475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels.
    Besheer T; Arafa M; El-Maksoud MA; Elalfy H; Hasson A; Zalata K; Elkashef W; Elshahawy H; Raafat D; Elemshaty W; Elsayed E; Zaghloul H; Razek AA; El-Bendary M
    Turk J Gastroenterol; 2018 May; 29(3):299-307. PubMed ID: 29755014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
    Lewin M; Poujol-Robert A; Boëlle PY; Wendum D; Lasnier E; Viallon M; Guéchot J; Hoeffel C; Arrivé L; Tubiana JM; Poupon R
    Hepatology; 2007 Sep; 46(3):658-65. PubMed ID: 17663420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.
    Pan S; Wang XQ; Guo QY
    World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver fibrosis with acoustic radiation force impulse imaging versus liver histology in patients with chronic hepatitis C: a pilot study.
    Kohla MAS; Abbasy M; Abozeid M; El-Abd O; Ezzat S; Kohla S; Abdel-Rahman M
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):951-955. PubMed ID: 28471822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
    Macaluso FS; Maida M; Cammà C; Cabibbo G; Cabibi D; Alduino R; Di Marco V; Craxì A; Petta S
    J Hepatol; 2014 Sep; 61(3):523-9. PubMed ID: 24815874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J
    Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of diagnosing and staging liver fibrosis with diffusion weighted imaging.
    Zhu NY; Chen KM; Chai WM; Li WX; Du LJ
    Chin Med Sci J; 2008 Sep; 23(3):183-6. PubMed ID: 18853855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruling-in and Ruling-out Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C Using a Shear Wave Measurement Method.
    Ferraioli G; Maiocchi L; Lissandrin R; Tinelli C; De Silvestri A; Filice C
    J Gastrointestin Liver Dis; 2017 Jun; 26(2):139-143. PubMed ID: 28617883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.
    Taouli B; Tolia AJ; Losada M; Babb JS; Chan ES; Bannan MA; Tobias H
    AJR Am J Roentgenol; 2007 Oct; 189(4):799-806. PubMed ID: 17885048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging.
    Bonekamp D; Bonekamp S; Ou HY; Torbenson MS; Corona-Villalobos CP; Mezey E; Kamel IR
    J Magn Reson Imaging; 2014 Nov; 40(5):1137-46. PubMed ID: 24989329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.